Andersen 1993 |
Comorbidity (stroke) |
Bakish 1992 |
Not a primary care setting |
Barrett 1999 |
Study included secondary care patients as well as primary care patients |
Barrrett 2001 |
Treatment in this study was undertaken by psychiatrists |
Borsun 1992 |
Comborbidity (COPD) |
Gomez 1968 |
Compared amitriptyline with an antipsychotic |
Houston 1983 |
Used the Leeds depression scale |
Jacobs 1965 |
A monoamine oxidase inhibitor |
Katz 2005 |
All medications combined, no single drug vs placebo |
Laakman 1995 |
Patients from psychiatrists and outpatient clinics |
Lehmann 1976 |
Not a true RCT (a CCT) |
Montgomery 1998 |
Patients were from psychiatrists (i.e., not in primary care setting) |
O'Hara 1978 |
Maprotiline compared with fluphenazine/nortriptyline; placebo was also used, but delivered in combination with active treatments and not as a comparator |
Paykel 1988 |
Primary data presented in Hollyman 1988 (see Characteristics of included studies table) |
Rickels 1968 |
Iprindole not in current clinical use |
Rickels 1971 |
No single antidepressant vs placebo |
Rickels 1991 |
Not primary care setting |
Schiffer 1975 |
No single antidepressant vs placebo |
SCTG 1985 |
Patients were of a mixed population (both anxiety and depression) |
Thompson 1994 |
Examined data originating from Doogan 1994 (included in this review) |